80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少?

[1]孫伏清,周密,周曉蘭,等.前纖維蛋白-1濃度與冠心病患者PCI術后2年患者發(fā)生主要不良心血管事件的關系[J].福建醫(yī)藥雜志,2022,44(04):17-19.
 SUN Fuqing,ZHOU Mi,ZHOU Xiaolan,et al.Association between baseline serum profilin-1 concentration and major adverse cardiovascular events in 2-year patients after percutaneous coronary intervention[J].FUJIAN MEDICAL JOURNAL,2022,44(04):17-19.
點擊復制

前纖維蛋白-1濃度與冠心病患者PCI術后2年患者發(fā)生主要不良心血管事件的關系()
分享到:

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
44
期數(shù):
2022年04期
頁碼:
17-19
欄目:
臨床研究
出版日期:
2022-08-15

文章信息/Info

Title:
Association between baseline serum profilin-1 concentration and major adverse cardiovascular events in 2-year patients after percutaneous coronary intervention
文章編號:
1002-2600(2022)04-0017-03
作者:
孫伏清周密周曉蘭林永芳郭城林凱金陳平
福建醫(yī)科大學附屬福清市醫(yī)院 福建省福清市醫(yī)院心血管內(nèi)科(福清 350300)
Author(s):
SUN Fuqing ZHOU Mi ZHOU Xiaolan LIN Yongfang GUO Cheng LIN Kaijin CHEN Ping
Department of Cardiology, Fuqing Municipal Hospital, Fuqing Municipal Hospital Affiliated to Fujian Medical University, Fuqing, Fujian 350300,China
關鍵詞:
冠心病前纖維蛋白-1心血管事件
Keywords:
coronary heart disease profilin-1 cardiovascular events
分類號:
R541.4; R540.4+6
文獻標志碼:
B
摘要:
目的 探討前纖維蛋白-1(Profilin-1)濃度與冠心病患者經(jīng)皮冠狀動脈介入治療(percutaneous coronary intervention,PCI)術后2年發(fā)生心血管事件的相關性。方法 本研究納入772例冠心病患者PCI術后患者進行為期2年隨訪。根據(jù)患者是否發(fā)生不良心血管事件,將患者分為A組(67例發(fā)生不良心血管事件)和B組(705例未發(fā)生不良心血管事件)。同時評估Profilin-1對PCI術后的患者2年內(nèi)發(fā)生不良心血管事件的預測價值。結(jié)果 冠心病患者隨訪2年發(fā)生心血管事件率與Profilin-1濃度,與B組比較,A組Profilin-1更高[133.85(110.09~157.55)ng/mL],差異均有統(tǒng)計學意義(P<0.01)。對PCI術后患者2年內(nèi)并發(fā)不良心血管事件的預測價值中,ROC曲線下面積為0.821[95%可信區(qū)間(0.762,0.81),P<0.01]。并且ROC曲線分析中建立的臨界值基礎上,將血清Profilin-1濃度分為高危組(≥120.205 ng/mL)和低危組(<120.205 ng/mL)。根據(jù)Kaplan-Meier生存曲線所示,血清Profilin-1濃度高危組較低危組的患者心血管事件的發(fā)生率明顯升高。結(jié)論 Profilin-1濃度在一定程度上可預測2年心血管事件發(fā)生。
Abstract:
Objective To investigate the levels of profilin-1 concentrations associated with 2-year major adverse cardiovascular events in patients after percutaneous coronary intervention.Methods A total of 772 patients who had been followed up for two years were enrolled in this study.Depending on whether the patients had adverse cardiovascular events, the patients were divided into Group A(67 cases with adverse ardiovascular events)and Group B(705 cases without adverse cardiovascular events).Profilin-1's predictive value was assessed in detecting 2-year major adverse cardiovascular events in patients after percutaneous coronary intervention.Results Compared with those without adverse cardiovascular events, patients with coronary heart disease who have been followed up for two years were detected higher levels of profilin-1 [133.85(110.09-157.55)ng/mL,P<0.01].For 2-year major adverse cardiovascular events in patients after percutaneous coronary intervention, the area under the curve was 0.786 by using ROC curve in predicting MACEs [95%CI(0.724-0.848), P<0.01)].ROC curve analysis was used to evaluate the optimal cut off values. Serums profilin-1 concentration was categorized into high(≥120.205 ng/mL)and low(<120.205 ng/mL)groups.According to the Kaplan-Meier survival curve, the incidence of cardiovascular events in patients with high risk group with serum profilin-1 concentration was significantly increased than those with low risk group.Conclusion The profilin-1 concentrations may predict 2-year major adverse cardiovascular events in patients after percutaneous coronary intervention.

參考文獻/References:

[1] 王燕逍翔,白建軍,宇傳華.基于全球視角的中國心血管病疾病負擔現(xiàn)狀及趨勢[J].公共衛(wèi)生與預防醫(yī)學,2021,32(06):6-11.
[2] Chen M S,John J M,Chew D P,et al.Bare metal stent restenosis is not a benign clinical entity[J].Am Heart J,2006,151(6):1260-1264.
[3] Carlsson L, Nyström L E, Sundkvist I, et al.Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells[J].J Mol Biol,1977,115(3):465-483.
[4] Caglayan E, Romeo G R, Kappert K,et al.Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells[J].PloS one,2010,5(10):e13608.
[5] 黎嘉雯,袁德山,蘇淑紅.血小板反應性對使用比伐盧定抗凝的擇期經(jīng)皮冠狀動脈介入治療患者臨床事件的影響[J].中華心血管病雜志,2021,49(08):783-789.
[6] Giulio R,Romeo,Andrius,et al.Oxysterol and diabetes activate STAT3 and control endothelial expression of profilin-1 via OSBP1[J].The Journal of biological chemistry,2008,283(15):9595-9605.

相似文獻/References:

[1]張健春 王新康.冠心病心律失常患者55例動態(tài)心電圖與常規(guī)心電圖對比分析[J].福建醫(yī)藥雜志,2018,40(06):68.
[2]黎 冉.阿托伐他汀鈣干預對冠心病患者圍術期心臟事件的影響[J].福建醫(yī)藥雜志,2020,42(01):26.
 LI Ran..Effect of atorvastatin calcium on perioperative cardiac events in patients with coronary heart disease[J].FUJIAN MEDICAL JOURNAL,2020,42(04):26.

備注/Memo

備注/Memo:
基金項目:2021年福州市衛(wèi)生健康中青年科學研究項目(2021-S-wq36)
更新日期/Last Update: 2022-08-15